ロード中...
Monitor tumor burden with circulating tumor DNA
There is a need to identify better biomarkers to monitor diseases and/or assess therapeutic responses. For those with cancer, one can identify DNA fragments that contain somatic mutations originating in the tumor DNA in plasma or serum. There have been several early studies suggesting that advances...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Landes Bioscience
2013
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3841207/ https://ncbi.nlm.nih.gov/pubmed/23792566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.25361 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|